Application of rituximab in treating six patients with chronic periaortitis and literature review

Objective By literature review to retrospectively study the clinical characteristics, diagnosis and treatment process and prognosis of chronic periaortitis (CP) treated with rituximab (RTX), and to improve the understanding of it. Methods To retrospectively analyze the clinical characteristics, laboratory indicators, changes of imaging findings and adverse reactions before and after RTX treatment of six CP patients admitted in the First Medical Center of Chinese PLA General Hospital from October 2014 to November 2020. The clinical remission was defined as the disappearance of clinical symptoms and hydronephrosis, erythrocyte sedimentation rate (ESR)